Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis

Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis

Monomodal systemic glucocorticoids remain the mainstay of treatment for bullous pemphigoid (BP). In this retrospective, single-arm study, we evaluated the feasibility (efficacy and tolerability) of the combination of methylprednisolone and low-dose (up to 12.5 mg/week) methotrexate (MP + MTX) for BP...

Full description

Bibliographic Details
Main Authors: Agoritsa Gravani, Georgios Gaitanis, Panagiota Spyridonos, Ioannis Alexis, Stelios Tigas, Ioannis D. Bassukas
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Clinical Medicine
Subjects:
bullous pemphigoid
methotrexate
glucocorticoid sparing
methylprednisolone
combination treatment
dipeptidyl peptidase-4 inhibitors
Online Access:https://www.mdpi.com/2077-0383/11/11/3193

Internet

https://www.mdpi.com/2077-0383/11/11/3193

Similar Items